JPH05124950A - Beautifying and whitening cosmetic composition - Google Patents
Beautifying and whitening cosmetic compositionInfo
- Publication number
- JPH05124950A JPH05124950A JP3308315A JP30831591A JPH05124950A JP H05124950 A JPH05124950 A JP H05124950A JP 3308315 A JP3308315 A JP 3308315A JP 30831591 A JP30831591 A JP 30831591A JP H05124950 A JPH05124950 A JP H05124950A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- whitening
- aquillariae
- lignum
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 239000002537 cosmetic Substances 0.000 title claims description 15
- 239000000284 extract Substances 0.000 claims abstract description 30
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 241000271309 Aquilaria crassna Species 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 239000002904 solvent Substances 0.000 abstract description 7
- 230000003013 cytotoxicity Effects 0.000 abstract description 6
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 6
- 206010014970 Ephelides Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000003061 melanogenesis Effects 0.000 abstract 1
- 230000008099 melanin synthesis Effects 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 7
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- -1 thiol compounds Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 208000001382 Experimental Melanoma Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 235000012730 carminic acid Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- YEDTWOLJNQYBPU-UHFFFAOYSA-N [Na].[Na].[Na] Chemical compound [Na].[Na].[Na] YEDTWOLJNQYBPU-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、優れた美白効果を有す
る美白用化粧料組成物に関し、さらに詳細には、特にシ
ミ、ソバカス等の予防又は治療に有効であって、優れた
美白効果を示すと共に、安定性および皮膚に対する高い
安全性を併せ持つ美白化粧料組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic composition having an excellent whitening effect, and more specifically, it is particularly effective in preventing or treating spots, freckles and the like, and has an excellent whitening effect. The present invention relates to a whitening cosmetic composition having both stability and high safety to the skin.
【0002】[0002]
【従来の技術】従来から、シミ、ソバカス等の予防又は
治療を目的として、ハイドロキノンおよびその配糖体、
コウジ酸およびその誘導体、アスコルビン酸およびその
誘導体、チオール系化合物、種々の動植物抽出物等の物
質を美白成分として配合する美白用化粧料が提案されて
いる。2. Description of the Related Art Conventionally, hydroquinone and its glycoside, for the purpose of preventing or treating spots, freckles, etc.,
There has been proposed a whitening cosmetic composition containing substances such as kojic acid and its derivatives, ascorbic acid and its derivatives, thiol compounds, and various animal and plant extracts as a whitening component.
【0003】[0003]
【発明が解決しようとする課題】しかしこれら化粧料に
は、種々の問題点が残されており、実用性の面で問題が
あった。 例えば、美白成分としてのハイドロキノンは
安全性に問題があり、また、ハイドロキノン配糖体、コ
ウジ酸およびその誘導体、アスコルビン酸およびその誘
導体等には、化粧料の配合成分として使用するには極性
が高すぎるという問題点がある。However, various problems remain in these cosmetics, and there is a problem in terms of practicality. For example, hydroquinone as a whitening component has a problem in safety, and hydroquinone glycosides, kojic acid and its derivatives, ascorbic acid and its derivatives, etc. have a high polarity for use as a blending component of cosmetics. There is a problem that it is too much.
【0004】さらに、グルタチオン、システイン等のチ
オール系化合物は、配合後の安定性に問題が残ってお
り、また、その他の動植物抽出物、例えば胎盤エキス、
アロエエキス等の配合も知られてはいるが、その美白効
果は満足出来るものではなかった。Further, thiol compounds such as glutathione and cysteine still have problems in stability after compounding, and other animal and plant extracts such as placenta extract,
Aloe extract and other ingredients are known, but their whitening effect was not satisfactory.
【0005】[0005]
【課題を解決するための手段】本発明者等は、優れた美
白効果を有する物質を見出すべく、マウスのB16メラ
ノーマ株を用いたメラニン生成抑制試験を指標に、種々
の植物抽出物についてスクリーニングを行った。 そし
てその結果、ジンチョウゲ科の植物であるジンコウ(Aq
uillaria agallocha)および白木香(Aquillaria sinen
sis)の木質部の抽出物(以下、「沈香抽出物」とい
う)が、メラニン生成を強く抑制すると共に細胞毒性が
極めて弱く、化粧料の美白成分として極めて有効である
ことを見出した。[Means for Solving the Problems] In order to find a substance having an excellent whitening effect, the present inventors screened various plant extracts using a melanin production inhibition test using a mouse B16 melanoma strain as an index. went. As a result, as a result, gingko (Aq
uillaria agallocha) and incense Shiraki (Aquillaria sinen)
It was found that an extract of the woody part of sis) (hereinafter referred to as "agarwood extract") strongly suppresses melanin production and has extremely weak cytotoxicity, and is extremely effective as a whitening ingredient of cosmetics.
【0006】本発明は、上記知見に基づいて完成された
ものであり、沈香抽出物を有効成分として含有する美白
化粧料用組成物を提供するものである。The present invention has been completed based on the above findings, and provides a composition for whitening cosmetics containing an agarwood extract as an active ingredient.
【0007】本発明において、美白化粧料組成物とは、
シミ、ソバカス等の予防又は治療に有効な皮膚用化粧料
組成物をいい、医薬部外品としてのローション、乳液、
クリーム、パック剤、石鹸等の薬用化粧品および医薬品
としてのローション、乳液、クリーム、軟膏等の皮膚外
用剤をも含むものである。In the present invention, the whitening cosmetic composition means
A skin cosmetic composition effective for the prevention or treatment of spots, freckles, etc., a lotion as a quasi drug, an emulsion,
It also includes cosmeceuticals such as creams, packs and soaps, and lotions as pharmaceuticals, and external preparations for skin such as emulsions, creams and ointments.
【0008】本発明で用いる沈香抽出物は、ジンコウま
たは白木香の木質部を溶媒で抽出することにより得られ
るものである。 ジンコウや白木香は、その樹脂化した
木質部が香木として古くから知られており、薬用として
は一種の鎮静作用、疲労回復作用を期待して、喘息、嘔
吐、腹痛、腰膝部の冷えに用いられている。 また、古
来から防虫香としても賞用されている。 しかしなが
ら、このものが美白剤として有効であるということは全
く知られていない。The agarwood extract used in the present invention is obtained by extracting the woody part of Jinko or Shirako scent with a solvent. Jinkou and Shiraki incense have long been known for their resinized woody parts as perfumes, and they are used for asthma, vomiting, abdominal pain, and coldness in the lower back and knees, with the expectation of a kind of sedative action and fatigue recovery action for medicinal purposes. Has been. It has also been used as an insect repellent since ancient times. However, it is completely unknown that this is effective as a whitening agent.
【0009】沈香抽出物を得るために用いられる溶媒と
しては、有効成分が効果的に抽出される溶媒であれば特
に限定されるものではないが、水またはアセトンや、メ
タノール、エタノール、プロパノール等の低級アルコー
ルのように水と混和する有機溶媒、もしくはそれらの混
液を用いるのが好ましく、水またはエタノールもしくは
その混液を用いるのがより好ましい。The solvent used to obtain the agarwood extract is not particularly limited as long as it is a solvent in which the active ingredient is effectively extracted, but water or acetone, methanol, ethanol, propanol and the like can be used. It is preferable to use an organic solvent that is miscible with water, such as a lower alcohol, or a mixed solution thereof, and it is more preferable to use water or ethanol or a mixed solution thereof.
【0010】沈香抽出物は、例えば、ジンコウ、白木香
の木質部や漢方薬局等で入手可能な沈香を、そのまま溶
媒で抽出して得ることもできるが、好ましくは、抽出効
率を高めるためには、これら原料をを細かく裁断してか
ら溶媒で抽出することが望ましい。抽出は、細かく裁断
した原料1gに対し、5〜100ml、好ましくは10
〜20mlの溶媒を用い、1日から1カ月間、好ましく
は2〜5日間、2〜4回に分けて室温で繰り返し行うこ
とが好ましい。また、沈香抽出物中の有効成分濃度を高
めるために、所望により、得られた沈香抽出物を更に、
濃縮、液液分配、吸着クロマトグラフィー、順相もしく
は逆相クロマトグラフィー等の手段に付すことも可能で
ある。The agarwood extract can be obtained, for example, by directly extracting the agarwood, which is available at the woody part of Jinko, Shiraki incense, Chinese herb pharmacy, etc., with a solvent, but preferably in order to enhance the extraction efficiency, It is desirable that these raw materials be finely cut and then extracted with a solvent. The extraction is 5 to 100 ml, preferably 10 per 1 g of the finely cut raw material.
It is preferable to use ~ 20 ml of a solvent for 1 to 1 month, preferably 2 to 5 days, and repeat 2 to 4 times at room temperature. Further, in order to increase the concentration of the active ingredient in the agarwood extract, the agarwood extract obtained may be further added, if desired.
It is also possible to apply means such as concentration, liquid-liquid distribution, adsorption chromatography, normal phase or reverse phase chromatography and the like.
【0010】本発明の美白化粧料組成物は、上記のよう
にして得られる沈香抽出物と、化粧料に一般に用いられ
ている成分、例えば、油性成分、界面活性剤、紫外線吸
収剤、低級アルコール、防腐剤、殺菌剤、色剤、粉末、
香料、水溶性高分子、緩衝剤などをその剤形に合わせ、
本発明の効果を損なわない範囲で適宜配合することによ
り調製される。The whitening cosmetic composition of the present invention comprises the agarwood extract obtained as described above and the components generally used in cosmetics, such as oily components, surfactants, ultraviolet absorbers and lower alcohols. , Preservatives, germicides, colorants, powders,
Match the dosage form with fragrance, water-soluble polymer, buffer, etc.
It is prepared by appropriately mixing the components within a range that does not impair the effects of the present invention.
【0011】本発明の美白化粧料組成物中の沈香抽出物
の配合量は、メラニン生成抑制作用ならびに皮膚の角質
透過性等を考慮して定めることが好ましいが、一般には
沈香抽出物を原材料換算で0.1〜50重量%、好まし
くは2〜20重量%程度とすれば良い。The content of the agarwood extract in the whitening cosmetic composition of the present invention is preferably determined in consideration of the melanin production inhibitory effect and the skin keratin permeability. Generally, the agarwood extract is converted into the raw material. It should be 0.1 to 50% by weight, preferably 2 to 20% by weight.
【0012】[0012]
【作用】本発明の有効成分である沈香抽出物がどのよう
に作用して美白効果を示すのかは未だ詳らかではない。
しかし、沈香抽出物がマウスのB16メラノーマ株を用
いたメラニン生成抑制試験で、細胞毒性を示さずにメラ
ニン生成を強く抑制することからみて、チロシンからメ
ラニン生成までのいずれかのステップにおいて、この反
応を阻害するものであることが予想される。It is not yet known how the agarwood extract, which is the active ingredient of the present invention, acts to exhibit a whitening effect.
However, in the melanin production inhibition test using the B16 melanoma strain of the mouse, the agarwood extract strongly inhibits melanin production without showing cytotoxicity, and this reaction was observed at any step from tyrosine to melanin production. It is expected to inhibit the
【0013】[0013]
【実施例】次に実施例を挙げ、本発明をさらに詳しく説
明するが、本発明はこれら実施例に何ら制約されるもの
ではない。The present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0014】実 施 例 1 沈香抽出物の調製:香木化した沈香(漢方薬商より入
手)2gを細かく裁断し、50%エタノール30mlを
加え、室温下で3日間抽出した。 抽出液を濾別した
後、残渣はさらに同様に2回再抽出を行い、得られた抽
出液を前の抽出液と合わせた。 これを濃縮乾固して、
粗抽出物176mgを得た。Example 1 Preparation of agarwood extract: 2 g of perfumed agarwood (obtained from Kampo medicine dealer) was finely cut, 30 ml of 50% ethanol was added, and the mixture was extracted at room temperature for 3 days. After the extract was filtered off, the residue was reextracted twice in the same manner, and the obtained extract was combined with the previous extract. Concentrate it to dryness,
176 mg of crude extract was obtained.
【0015】実 施 例 2 メラニン生成抑制試験:メラニン生成抑制試験はマウス
のメラノーマ細胞を用いて、次の様に行った。先ず、1
×105個のB16メラノーマ細胞を、10%(v/v) 牛
胎児血清を含むイーグル最少栄養培地5mlを入れた直
径60mmのシャーレに播種し、5%(v/v) 炭酸ガスに
調整した炭酸ガスインキュベーターで37℃で24時間
培養した。 次いでこのシャーレに純水または20%エ
タノールに溶解した試料を50μl添加した。同条件で
さらに5日間培養した後、トリプシン処理により細胞を
回収し、その白色化度を肉眼で評価し、同時に、細胞塊
体積の変化を肉眼で判定し、細胞毒性の指標とした。Example 2 Melanin production inhibition test: The melanin production inhibition test was carried out as follows using mouse melanoma cells. First, 1
× 10 5 B16 melanoma cells were seeded in a petri dish having a diameter of 60 mm containing 5 ml of Eagle's minimal nutrient medium containing 10% (v / v) fetal bovine serum and adjusted to 5% (v / v) carbon dioxide. The cells were cultured in a carbon dioxide gas incubator at 37 ° C for 24 hours. Next, 50 μl of a sample dissolved in pure water or 20% ethanol was added to this petri dish. After further culturing for 5 days under the same conditions, cells were collected by trypsin treatment, the degree of whitening was visually evaluated, and at the same time, the change in cell mass volume was visually evaluated and used as an index of cytotoxicity.
【0016】この測定法を用いて、実施例1で得られた
沈香抽出物について、種々の濃度でメラニン生成抑制を
測定した。 この結果を表1に示す。 なお、比較のた
め、美白効果が知られているアルブチン(S. Akiu 他、
Proc. Jpn. Soc. Invest. Dermatol., 12巻 138頁(198
8))も同様に測定した。Using this measurement method, the agarwood extract obtained in Example 1 was measured for melanin production inhibition at various concentrations. The results are shown in Table 1. For comparison, arbutin (S. Akiu et al., Whose whitening effect is known,
Proc. Jpn. Soc. Invest. Dermatol., 12 Vol. 138 (198
8)) was also measured in the same manner.
【0017】 * 白色化度判定基準: 判 定 内 容 ++ 白色化度が大きい。 + 白色化度は中くらいである。 ± やや白色化する。 − 白色化しない。[0017] * Whiteness judgment criteria: Judgment content ++ High whiteness. + Moderate whiteness. ± slightly whitened. -No whitening.
【0018】表1から明らかなように、沈香抽出物はア
ルブチンに比較して5倍以上のメラニン生成抑制活性を
示した。 また、アルブチンが20μg/mlの試料添
加で細胞塊体積の減少を認め、50μg/mlの試料添
加では細胞が死滅したのに比べ、沈香抽出物は50μg
/mlの試料添加でも細胞塊体積の変化を認めず、細胞
毒性が極めて弱いことが判明した。As is clear from Table 1, the agarwood extract showed a melanin production inhibitory activity which was 5 times or more that of arbutin. In addition, arbutin showed a decrease in cell mass volume when the sample was added at 20 μg / ml, and cells were killed when the sample was added at 50 μg / ml, whereas the agarwood extract was 50 μg.
It was found that the cytotoxicity was extremely weak, with no change in the volume of the cell mass observed even when the sample was added in the amount of / ml.
【0019】実 施 例 3 美白クリームの製造: 〔 処 方 〕 A 実施例1の抽出物 0.01g 精 製 水 5.54g B 3−サクシニルオキシグリチル レチン酸第二ナトリウム 0.05g C スクワラン 10.00g ミリスチン酸オクチルドデシル 8.00g マイクロクリスタリンワックス 4.00g ベヘニルアルコール 3.00g 親油型モノステアリン酸グリセリン 2.50g モノステアリン酸ポリオキシ エチレンソルビタン(20E.O.) 2.50g D 1,3−ブチレングリコール 10.00g パラオキシ安息香酸メチル 0.10g 精 製 水 54.00g E 香 料 0.30gExample 3 Production of whitening cream: [Method] A Extract of Example 1 0.01 g Purified water 5.54 g B 3-succinyloxyglycyl retinoic acid disodium sodium 0.05 g C squalane 10 0.000 g Octyldodecyl myristate 8.00 g Microcrystalline wax 4.00 g Behenyl alcohol 3.00 g Lipophilic glyceryl monostearate 2.50 g Polyoxyethylene sorbitan monostearate (20 E.O.) 2.50 g D 1,3-butylene Glycol 10.00 g Methyl paraoxybenzoate 0.10 g Purified water 54.00 g E Fragrance 0.30 g
【0020】〔 製 法 〕80〜85℃に加熱したDに
Bを加え、これに80〜85℃に加熱溶解したCをホモ
ミキサーで撹拌しながら加え、均一に乳化した。これを
室温で徐々に約50℃に冷却し、Eおよび懸濁したAを
加えた。さらに撹拌を続けながら室温まで冷却し、美白
クリームを製造した。このようにして製造した美白クリ
ームは、美白効果に優れたものであった。[Production Method] B was added to D heated to 80 to 85 ° C., and C which was heated and dissolved at 80 to 85 ° C. was added thereto with stirring with a homomixer to uniformly emulsify. It was gradually cooled to about 50 ° C. at room temperature and E and suspended A were added. The whitening cream was manufactured by further cooling to room temperature while continuing stirring. The whitening cream thus produced had an excellent whitening effect.
【0021】実 施 例 4 カーマインローションの製造: 〔 処 方 〕 A 酸化亜鉛 1.30g 無水ケイ酸 1.10g タ ル ク 2.00g ベ ン ガ ラ 0.01g ポリオキシエチレン ステアリン酸アミド(4E.O.) 0.05g B 実施例1の抽出物 0.01g エタノール 5.59g 精 製 水 5.00g C 濃グリセリン 3.00g カ ン フ ル 0.10g パラオキシ安息香酸メチル 0.05g 香 料 0.05g D 精 製 水 81.74gExample 4 Production of Carmine Lotion: [Method] A zinc oxide 1.30 g silicic acid anhydride 1.10 g tar 2.00 g bengala 0.01 g polyoxyethylene stearic acid amide (4E. O.) 0.05 g B Extract of Example 1 0.01 g Ethanol 5.59 g Purified water 5.00 g C Concentrated glycerin 3.00 g Caffle 0.10 g Methyl paraoxybenzoate 0.05 g Fragrance 0.1 05g D Purified water 81.74g
【0022】〔 製 法 〕Dの約60gをAに加え、ホ
モミキサーで均一に分散させて粉体分散液を作製した。
これにBの溶液およびCを加え、さらにDの残部を加
え、さらにホモミキサーで均一に分散させてカーマイン
ローションを製造した。このようにして製造したカーマ
インローションは、ほてり感を鎮め、美白効果に優れた
ものであった。[Production Method] About 60 g of D was added to A and uniformly dispersed with a homomixer to prepare a powder dispersion.
A solution of B and C were added to this, the rest of D was added, and the mixture was uniformly dispersed with a homomixer to produce a carmine lotion. The carmine lotion produced in this manner had a hot whitening effect and an excellent whitening effect.
【0023】実 施 例 5 美白軟膏の製造: 〔 処 方 〕 A マクロゴール4000 47.50g マクロゴール400 47.50g B 実施例1の抽出物 0.03g 精 製 水 4.97gExample 5 Production of whitening ointment: [Method] A Macrogol 4000 47.50 g Macrogol 400 47.50 g B Extract from Example 1 0.03 g Purified water 4.97 g
【0024】〔 製 法 〕マクロゴール4000および
マクロゴール400を水浴上で65℃に加温して溶解
し、均一に混合してマクロゴール軟膏基剤を製造した。
これにBの溶液を練合して美白軟膏を製造した。このよ
うにして製造した美白軟膏は、美白効果に優れたもので
あった。[Manufacturing Method] Macrogol 4000 and Macrogol 400 were heated to 65 ° C. in a water bath to dissolve, and uniformly mixed to manufacture a Macrogol ointment base.
The solution of B was kneaded with this to produce a whitening ointment. The whitening ointment thus produced was excellent in whitening effect.
【0025】[0025]
【発明の効果】本発明の沈香抽出物は、細胞毒性を示す
ことなくメラニン生成を著しく抑制する。 従って、本
発明の沈香抽出物あるいはその精製物を含有する美白用
化粧料組成物は、安全で美白効果が高いものである。The agarwood extract of the present invention remarkably suppresses melanin production without showing cytotoxicity. Therefore, the cosmetic composition for whitening containing the agar extract or the purified product of the present invention is safe and has a high whitening effect.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 浅見 純生 大阪府三島郡島本町若山台1丁目1番1号 サントリー株式会社基礎研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Junsei Asami 1-1-1, Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka Suntory Ltd.
Claims (1)
とを特徴とする美白用化粧料組成物。1. A whitening cosmetic composition comprising an agarwood extract as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3308315A JPH05124950A (en) | 1991-10-29 | 1991-10-29 | Beautifying and whitening cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3308315A JPH05124950A (en) | 1991-10-29 | 1991-10-29 | Beautifying and whitening cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05124950A true JPH05124950A (en) | 1993-05-21 |
Family
ID=17979575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3308315A Pending JPH05124950A (en) | 1991-10-29 | 1991-10-29 | Beautifying and whitening cosmetic composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05124950A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2003137762A (en) * | 2001-11-01 | 2003-05-14 | Noevir Co Ltd | Skin care preparation |
JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
JP2008179598A (en) * | 2006-12-27 | 2008-08-07 | Nof Corp | Melanin production inhibitor comprising as an active ingredient an extract from the genus Thymellaa, and whitening pharmaceutical composition, cosmetic composition, and food containing the same |
JP2008303198A (en) * | 2007-06-11 | 2008-12-18 | Api Co Ltd | GENKWANIN 5-O-beta-PRIMEVEROSIDE-CONTAINING EXTRACT, PROCESS FOR EXTRACTION OF GENKWANIN 5-O-beta-PRIMEVEROSIDE, LAXATIVE, AND FOOD AND DRINK PRODUCTS |
CN104523520A (en) * | 2014-12-19 | 2015-04-22 | 韩嘉 | Application of Aquilaria sinensis extract used as effective constituent for whitening |
CN106361648A (en) * | 2016-11-08 | 2017-02-01 | 黄成林 | Composition with skin whitening, freckle removing and acne removing functions and preparation method and application of composition |
JP2019112363A (en) * | 2017-12-25 | 2019-07-11 | 小林製薬株式会社 | Regulatory t-cell differentiation inhibitor and immunomodulation composition |
-
1991
- 1991-10-29 JP JP3308315A patent/JPH05124950A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2003137762A (en) * | 2001-11-01 | 2003-05-14 | Noevir Co Ltd | Skin care preparation |
JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
JP2008179598A (en) * | 2006-12-27 | 2008-08-07 | Nof Corp | Melanin production inhibitor comprising as an active ingredient an extract from the genus Thymellaa, and whitening pharmaceutical composition, cosmetic composition, and food containing the same |
JP2008303198A (en) * | 2007-06-11 | 2008-12-18 | Api Co Ltd | GENKWANIN 5-O-beta-PRIMEVEROSIDE-CONTAINING EXTRACT, PROCESS FOR EXTRACTION OF GENKWANIN 5-O-beta-PRIMEVEROSIDE, LAXATIVE, AND FOOD AND DRINK PRODUCTS |
CN104523520A (en) * | 2014-12-19 | 2015-04-22 | 韩嘉 | Application of Aquilaria sinensis extract used as effective constituent for whitening |
CN106361648A (en) * | 2016-11-08 | 2017-02-01 | 黄成林 | Composition with skin whitening, freckle removing and acne removing functions and preparation method and application of composition |
JP2019112363A (en) * | 2017-12-25 | 2019-07-11 | 小林製薬株式会社 | Regulatory t-cell differentiation inhibitor and immunomodulation composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07126149A (en) | Cosmetic composition for beautifying and whitening | |
JPH09263534A (en) | Promoter for melanogenesis | |
WO2021017835A1 (en) | Enhanced whitening cosmetic composition | |
JPH0930946A (en) | Beautifying and whitening dermal preparation for external use | |
JP2952636B2 (en) | Melanin production inhibitor, method for producing the same, and whitening cosmetic containing the same | |
JP2749218B2 (en) | Cosmetic composition for whitening | |
JPH068249B2 (en) | Topical agent for suppressing melanin production | |
JPH05124950A (en) | Beautifying and whitening cosmetic composition | |
JPH05163135A (en) | Beautifying cosmetic composition | |
JPH10330219A (en) | Melanogenesis inhibitor and skin whitening agent | |
JP2003160461A (en) | Skin care preparation | |
KR20130114493A (en) | Cosmetic compositions comprising the extract of dendropanax morbiferum as an active ingredient | |
JPH0812560A (en) | Skin external preparation | |
JP2005008548A (en) | External preparation for skin | |
JP2001114636A (en) | Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion | |
JPH07238011A (en) | Skin-beautifying cosmetic composition | |
JPH11349436A (en) | Collagenase inhibitor and skin agent containing the same and used for external use | |
JP4223574B2 (en) | Cosmetic composition for whitening | |
JPH01139517A (en) | Cosmetic | |
JPH11193243A (en) | Skin preparation for external use | |
KR101156970B1 (en) | Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same | |
JP2002029979A (en) | Histamine h2 receptor antagonistic agent and skin care preparation | |
JPH0930948A (en) | Beautifying and whitening dermal preparation for external use | |
JP3150841B2 (en) | External preparation for skin | |
JPH0971522A (en) | Skin preparation for external use for lightening skin |